scispace - formally typeset
Search or ask a question
Author

Hong Liu

Bio: Hong Liu is an academic researcher from Southwest University. The author has contributed to research in topics: Silica fume & Cross-sectional study. The author has an hindex of 3, co-authored 5 publications receiving 1213 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: The prevalence of chronic kidney disease in China was high in north and southwest and southwest regions compared with other regions, and economic development was independently associated with the presence of albuminuria.

1,588 citations

Journal ArticleDOI
TL;DR: The domestic PD solution (Changfu) was proven to be as effective as Baxter dialysis solution and its difference between 6 L and 8 L dosage and its changes of primary and secondary efficacy indices were evaluated.
Abstract: BackgroundA multi-center large scale study is needed to confirm the efficacy and safety of domestic peritoneal dialysis (PD) solutions. Some researchers believe that 6 L/d is enough for adequate dialysis, but there is no multi-center prospective study on Chinese population to confirm this. In this s

8 citations

Patent
19 Apr 2017
TL;DR: In this article, a modified high-sulfate-resistant corrosion-resistant concrete comprising cement, fly ash, mineral powder, silica fume, sand, stones, a new high performance admixture and water is described.
Abstract: The invention discloses modified high-sulfate-resistant corrosion-resistant concrete comprising cement, fly ash, mineral powder, silica fume, sand, stones, a new high performance admixture and water; and the modified high-sulfate-resistant corrosion-resistant concrete has the advantages of low cost, wide applicability and good sulfate-resistant performance.

5 citations

Patent
31 Oct 2017
TL;DR: In this article, a novel retarder for sulfate aluminum cement and a preparation method thereof is presented. But the retarder is mainly prepared from the following components in parts by weight: 45-60 parts of maleic anhydride, 0.30-0.65 part of tungstic acid, 75-150 parts of 30% hydrogen peroxide, 5-35 parts of potassium hydroxide, 12-37 parts of anhydrous boric acid, 8-15 parts of sodium gluconate and 5-10 parts of tripolyphosph
Abstract: The invention discloses novel retarder for sulfate aluminum cement and a preparation method thereof. The retarder is mainly prepared from the following components in parts by weight: 45-60 parts of maleic anhydride, 0.30-0.65 part of tungstic acid, 75-150 parts of 30% hydrogen peroxide, 5-35 parts of potassium hydroxide, 12-37 parts of anhydrous boric acid, 8-15 parts of sodium gluconate and 5-10 parts of sodium tripolyphosphate. The novel retarder has the advantages that the initial setting time of the sulfate aluminum cement is controlled between 45-300 minutes, and the construction requirement for most concrete constructions can be met.

Cited by
More filters
Journal ArticleDOI
TL;DR: Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced, but awareness of the disorder remains low in many communities and among many physicians.

3,207 citations

Journal ArticleDOI
TL;DR: The burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected.

2,370 citations

Journal ArticleDOI
06 Jul 2016-PLOS ONE
TL;DR: CKD has a high global prevalence with a consistent estimated global CKD prevalence of between 11 to 13% with the majority stage 3, and future research should evaluate intervention strategies deliverable at scale to delay the progression of CKD and improve CVD outcomes.
Abstract: © 2016 Hill et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associated with increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of life. CKD is usually asymptomatic until later stages and accurate prevalence data are lacking. Thus we sought to determine the prevalence of CKD globally, by stage, geographical location, gender and age. A systematic review and meta-analysis of observational studies estimating CKD prevalence in general populations was conducted through literature searches in 8 databases. We assessed pooled data using a random effects model. Of 5,842 potential articles, 100 studies of diverse quality were included, comprising 6,908,440 patients. Global mean(95%CI) CKD prevalence of 5 stages 13.4%(11.7-15.1%), and stages 3-5 was 10.6%(9.2-12.2%). Weighting by study quality did not affect prevalence estimates. CKD prevalence by stage was Stage-1 (eGFR>90+ACR>30): 3.5% (2.8-4.2%); Stage-2 (eGFR 60-89+ACR>30): 3.9% (2.7-5.3%); Stage-3 (eGFR 30-59): 7.6% (6.4-8.9%); Stage-4 = (eGFR 29-15): 0.4% (0.3-0.5%); and Stage-5 (eGFR<15): 0.1% (0.1-0.1%). CKD has a high global prevalence with a consistent estimated global CKD prevalence of between 11 to 13% with the majority stage 3. Future research should evaluate intervention strategies deliverable at scale to delay the progression of CKD and improve CVD outcomes.

2,321 citations

Journal ArticleDOI
TL;DR: The global prevalence and absolute burden of CKD in 2010 was estimated by pooling data from population-based studies by searching MEDLINE (January 1990 to December 2014), International Society of Nephrology Global Outreach Program funded projects, and bibliographies of retrieved articles and selected 33 studies reporting gender- and age-specific prevalence in representative population samples.

582 citations